Mario Schlosser Sells 390,405 Shares of Oscar Health, Inc. (NYSE:OSCR) Stock

Oscar Health, Inc. (NYSE:OSCR) insider Mario Schlosser sold 390,405 shares of the company’s stock in a transaction on Thursday, November 16th. The stock was sold at an average price of $7.12, for a total transaction of $2,779,683.60. Following the completion of the transaction, the insider now owns 57,317 shares of the company’s stock, valued at $408,097.04. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link.

Oscar Health Stock Performance

Shares of NYSE:OSCR opened at $8.28 on Tuesday. The company has a market cap of $1.87 billion, a price-to-earnings ratio of -5.21 and a beta of 1.10. The company has a 50-day moving average price of $5.80 and a 200-day moving average price of $6.96. The company has a current ratio of 1.36, a quick ratio of 1.36 and a debt-to-equity ratio of 0.32. Oscar Health, Inc. has a 12 month low of $2.05 and a 12 month high of $9.89.

Oscar Health (NYSE:OSCR) last issued its quarterly earnings data on Tuesday, November 7th. The company reported ($0.29) EPS for the quarter, beating the consensus estimate of ($0.47) by $0.18. The firm had revenue of $1.44 billion during the quarter, compared to the consensus estimate of $1.42 billion. Oscar Health had a negative net margin of 6.39% and a negative return on equity of 37.51%. The company’s quarterly revenue was up 47.2% compared to the same quarter last year. During the same period in the prior year, the firm posted ($0.91) earnings per share. As a group, equities analysts anticipate that Oscar Health, Inc. will post -1.3 EPS for the current year.

Hedge Funds Weigh In On Oscar Health

Several hedge funds and other institutional investors have recently modified their holdings of OSCR. Covestor Ltd raised its stake in shares of Oscar Health by 310.0% during the second quarter. Covestor Ltd now owns 3,329 shares of the company’s stock valued at $27,000 after acquiring an additional 2,517 shares during the last quarter. CI Private Wealth LLC bought a new position in Oscar Health in the fourth quarter worth about $38,000. Royal Bank of Canada raised its stake in Oscar Health by 959.5% in the third quarter. Royal Bank of Canada now owns 10,129 shares of the company’s stock worth $50,000 after buying an additional 9,173 shares in the last quarter. Dark Forest Capital Management LP raised its stake in Oscar Health by 5,243.2% in the first quarter. Dark Forest Capital Management LP now owns 7,801 shares of the company’s stock worth $51,000 after buying an additional 7,655 shares in the last quarter. Finally, Alpine Global Management LLC bought a new position in Oscar Health in the fourth quarter worth about $54,000. 66.70% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

Several analysts have issued reports on the stock. Morgan Stanley upped their price target on shares of Oscar Health from $5.00 to $7.50 and gave the company an “equal weight” rating in a research report on Wednesday, August 30th. The Goldman Sachs Group upped their price target on shares of Oscar Health from $5.50 to $7.50 and gave the company a “neutral” rating in a research report on Thursday, August 10th. Bank of America upgraded shares of Oscar Health from a “neutral” rating to a “buy” rating and upped their price target for the company from $8.00 to $9.00 in a research report on Thursday, November 2nd. Finally, Credit Suisse Group upped their price target on shares of Oscar Health from $7.00 to $8.50 and gave the company an “outperform” rating in a research report on Wednesday, August 9th. Three research analysts have rated the stock with a hold rating and two have given a buy rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of “Hold” and a consensus target price of $7.70.

Oscar Health Company Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers Individual and Small Group, and Medicare Advantage plans, as well as +Oscar, a technology driven platform designed to help providers and payors directly enable their shift to value-based care It also provides reinsurance products.